DDR2 and breast cancer: To determine whether the partial effects of tyrosine kinase-inactive DDR2 in tumor cells was relevant in vivo, we generated Balb/c-derived 4T1 mouse mammary tumor cell lines depleted of DDR2 (using shRNA) and lines rescued with species-specific WT, K608E or ΔKD DDR2 isoforms.